-
EP0758902
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0758902
| EP0758902 - COMPOSITIONS AND TREATMENT FOR MULTIPLE SCLEROSIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.04.2000 Database last updated on 02.11.2024 | Most recent event Tooltip | 20.04.2000 | Application deemed to be withdrawn | published on 07.06.2000 [2000/23] | Applicant(s) | For all designated states IMMULOGIC PHARMACEUTICAL CORPORATION 610 Lincoln Street Waltham Massachusetts 02154 / US | [N/P] |
| Former [1997/09] | For all designated states IMMULOGIC PHARMACEUTICAL CORPORATION 610 Lincoln Street Waltham, Massachusetts 02154 / US | Inventor(s) | 01 /
HSU, Di-Hwei 246 Ventura Avenue Palo Alto, CA 94304 / US | 02 /
SMILEK, Dawn 12589 Fredericksburg Saratoga, CA 95070 / US | 03 /
SHI, Jia, Dong 98 Chruch Street 1 Mountain View, CA 94041 / US | [1997/09] | Representative(s) | Hutchins, Michael Richard, et al FRY HEATH & SPENCE LLP The Gables Massetts Road Horley Surrey RH6 7DQ / GB | [N/P] |
| Former [1997/09] | Hutchins, Michael Richard, et al FRY HEATH & SPENCE The Old College 53 High Street Horley Surrey RH6 7BN / GB | Application number, filing date | 95918988.7 | 04.05.1995 | [1997/09] | WO1995US05605 | Priority number, date | US19940241246 | 10.05.1994 Original published format: US 241246 | US19940328224 | 25.10.1994 Original published format: US 328224 | [1997/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9530435 | Date: | 16.11.1995 | [1995/49] | Type: | A1 Application with search report | No.: | EP0758902 | Date: | 26.02.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.11.1995 takes the place of the publication of the European patent application. | [1997/09] | Search report(s) | International search report - published on: | EP | 07.12.1995 | Classification | IPC: | A61K38/21, C07K14/47, A61K38/17, // (A61K38/21, 38:17) | [1997/09] | CPC: |
C07K14/4713 (EP);
A61K38/215 (EP);
A61P25/00 (EP);
A61P43/00 (EP)
| C-Set: |
A61K38/215, A61K2300/00 (EP);
A61K38/215, A61K38/1709 (EP) | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/09] | Extension states | LT | 03.12.1996 | LV | 03.12.1996 | SI | 03.12.1996 | Title | German: | ZUSAMMENSETZUNGEN UND EINE BEHANDLUNG FUER MULTIPLE SKLEROSE | [1997/09] | English: | COMPOSITIONS AND TREATMENT FOR MULTIPLE SCLEROSIS | [1997/09] | French: | COMPOSITIONS ET TRAITEMENT DE LA SCLEROSE EN PLAQUES | [1997/09] | Entry into regional phase | 03.12.1996 | National basic fee paid | 03.12.1996 | Designation fee(s) paid | 03.12.1996 | Examination fee paid | Examination procedure | 07.12.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 03.12.1996 | Examination requested [1997/09] | 01.12.1999 | Application deemed to be withdrawn, date of legal effect [2000/23] | 12.01.2000 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2000/23] | Fees paid | Renewal fee | 12.05.1997 | Renewal fee patent year 03 | 11.05.1998 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.05.1999 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9321222 (AUTOIMMUNE INC [US], et al) [X] 11-15 * page 28 - page 36; example 1 *; | [X]WO9404121 (AUTOIMMUNE INC [US]) [X] 11-15 * page 40 - page 42; examples 3,4 * * page 49 *; | [X] - ABREU, "INTERFERON IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE):EFFECTS OF EXOGENOUS INTERFERON ON THE ANTIGEN-ENHANCED ADOPTIVE TRANSFER OF EAE", MEDLINE, FILE SERVER STN KARLSRUHE [X] 5,6,10 * abstract * | [DA] - PANITCH ET AL, "CLINICAL TRIALS OF INTERFERONS IN MULTIPLE SCLEROSIS.WHAT HAVE WE LEARNED", JOURNAL OF NEUROIMMUNOLOGY, vol. 46, no. 1+2, doi:doi:10.1016/0165-5728(93)90245-T, pages 155 - 164, XP023694964 [DA] * see summary,page 155 * DOI: http://dx.doi.org/10.1016/0165-5728(93)90245-T |